Barclays Begins Coverage on American Healthcare REIT (NYSE:AHR)

Equities research analysts at Barclays began coverage on shares of American Healthcare REIT (NYSE:AHR) in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm set an “overweight” rating and a $61.00 price target on the stock. Barclays‘s target price would suggest a potential upside of 13.01% from the stock’s current price.

Several other brokerages have also recently issued reports on AHR. Citigroup upgraded shares of American Healthcare REIT from a “neutral” rating to a “buy” rating and set a $55.00 price target for the company in a research report on Monday, June 22nd. KeyCorp lifted their price target on shares of American Healthcare REIT from $55.00 to $58.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Royal Bank Of Canada boosted their price objective on shares of American Healthcare REIT from $54.00 to $56.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Weiss Ratings downgraded American Healthcare REIT from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 2nd. Finally, Scotiabank lowered their target price on American Healthcare REIT from $59.00 to $51.00 and set a “sector outperform” rating for the company in a research report on Thursday, June 18th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $55.42.

American Healthcare REIT Stock Performance

Shares of AHR stock opened at $53.98 on Tuesday. The firm has a market capitalization of $10.40 billion, a price-to-earnings ratio of 30.24, a PEG ratio of 1.84 and a beta of 0.77. The company has a current ratio of 0.45, a quick ratio of 0.45 and a debt-to-equity ratio of 0.28. The business’s 50-day moving average price is $49.58 and its 200-day moving average price is $49.34. American Healthcare REIT has a 12 month low of $35.54 and a 12 month high of $55.75.

American Healthcare REIT (NYSE:AHR) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.34). The firm had revenue of $650.77 million during the quarter, compared to analyst estimates of $667.57 million. American Healthcare REIT had a net margin of 4.23% and a return on equity of 3.33%. The business’s quarterly revenue was up 20.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.38 EPS. American Healthcare REIT has set its FY 2026 guidance at 2.030-2.090 EPS. Equities research analysts forecast that American Healthcare REIT will post 2.07 EPS for the current year.

Insiders Place Their Bets

In other news, CFO Brian Peay sold 25,000 shares of the stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $50.70, for a total transaction of $1,267,500.00. Following the transaction, the chief financial officer owned 152,700 shares of the company’s stock, valued at $7,741,890. This represents a 14.07% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Mark E. Foster sold 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $48.58, for a total value of $121,450.00. Following the completion of the sale, the executive vice president owned 52,995 shares of the company’s stock, valued at approximately $2,574,497.10. This represents a 4.50% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 29,500 shares of company stock worth $1,485,590 in the last quarter. 0.75% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On American Healthcare REIT

A number of large investors have recently modified their holdings of AHR. Sigma Planning Corp grew its position in American Healthcare REIT by 1.5% in the 1st quarter. Sigma Planning Corp now owns 15,191 shares of the company’s stock valued at $716,000 after purchasing an additional 222 shares during the period. NFSG Corp raised its holdings in American Healthcare REIT by 8.8% during the first quarter. NFSG Corp now owns 2,993 shares of the company’s stock worth $141,000 after buying an additional 242 shares during the last quarter. Centaurus Financial Inc. raised its holdings in American Healthcare REIT by 4.7% during the first quarter. Centaurus Financial Inc. now owns 5,913 shares of the company’s stock worth $279,000 after buying an additional 266 shares during the last quarter. Spire Wealth Management lifted its stake in shares of American Healthcare REIT by 1.8% in the fourth quarter. Spire Wealth Management now owns 16,127 shares of the company’s stock valued at $759,000 after buying an additional 279 shares in the last quarter. Finally, Militia Capital Partners LP lifted its stake in shares of American Healthcare REIT by 1.6% in the third quarter. Militia Capital Partners LP now owns 19,100 shares of the company’s stock valued at $802,000 after buying an additional 300 shares in the last quarter. 16.68% of the stock is currently owned by institutional investors.

About American Healthcare REIT

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.